Association between Vitamin D Deficiency and Disease Activity in Systemic Lupus Erythematosus (SLE).
DOI:
https://doi.org/10.29309/TPMJ/2026.33.07.10443Keywords:
Autoantibodies, Disease Activity, Hydroxycholecalciferols, Immunomodulation Lupus Erythematosus, Systemic, Vitamin D DeficiencyAbstract
Objective: To evaluate the association between SLE patients' disease activity and blood 25-hydroxyvitamin D [25(OH)D] levels. Study Design: Cross-sectional Analytical Investigation. Setting: Bahawal Victoria Hospital, Bahawalpur. Period: January and December 2025. Methods: A total of 85 adult SLE patients who met the 2019 EULAR/ACR criteria participated SLEDAI-2K, BILAG-2004, PGA, and serological markers were used to evaluate disease activity. Vitamin D status was categorized per standard thresholds. Spearman’s correlation and multivariable linear and logistic regression models were used, adjusting for age, gender, BMI, prednisolone dose, hydroxychloroquine use and sun avoidance. Results: Vitamin D deficiency (<20 ng/mL) was present in 63.5% of patients. Significant inverse correlation was observed between 25(OH)D and SLEDAI-2K (ρ = –0.34, p = 0.001). Each 10 mg/mL increase in 25(OH)D was linked with a 1.8-point reduction in SLEDAI-2K (p = 0.002). Deficient patients had 3.7-fold higher odds of high disease activity (adjusted OR = 3.72, p = 0.025). Conclusion: Deficiency of Vitamin D is common and independently linked with higher disease activity in Pakistani SLE patients, supporting routine screening and repletion.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The Professional Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.